Literature DB >> 29781042

Inequities in genetic testing for hereditary breast cancer: implications for public health practice.

Ambreen Sayani1,2.   

Abstract

The Ontario Breast Screening Program for women with a genetic predisposition to breast cancer is one of the first international models of a government-funded public health service that offers systematic genetic screening to women at a high risk of breast cancer. However, since the implementation of the program in 2011, enrolment rates have been lower than anticipated. Whilst there may be several reasons for this to happen, it does call into consideration the 'inverse equity law', whereby the more advantaged in society are the first to participate and benefit from universal health services. An outcome of this phenomenon is an increase in the health divide between those that are at a social advantage versus those that are not. Using an intersectionality lens, this paper explores the role of the social determinants of health and social identity in creating possible barriers in the access to genetic screening for hereditary breast cancer, and the implications for public health practice in recognising and ameliorating these differences.

Entities:  

Keywords:  BRCA; Breast cancer; Disparity; Equity; Genetic testing; Hereditary breast cancer; Intersectionality; Public health; Social determinants of health; Social justice; Social location

Year:  2018        PMID: 29781042      PMCID: PMC6325036          DOI: 10.1007/s12687-018-0370-8

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  33 in total

1.  Confronting genetic testing disparities: knowledge is power.

Authors:  Michael Hall; Olufunmilayo I Olopade
Journal:  JAMA       Date:  2005-04-13       Impact factor: 56.272

2.  The concepts and principles of equity and health.

Authors:  M Whitehead
Journal:  Int J Health Serv       Date:  1992       Impact factor: 1.663

Review 3.  Breast cancer and ovarian cancer genetics.

Authors:  Richard F Edlich; Kathryne L Winters; Kant Y Lin
Journal:  J Long Term Eff Med Implants       Date:  2005

4.  Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.

Authors:  Emily A Peterson; Kara J Milliron; Karen E Lewis; Susan D Goold; Sofia D Merajver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

5.  Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.

Authors:  Katrina Armstrong; Ellyn Micco; Amy Carney; Jill Stopfer; Mary Putt
Journal:  JAMA       Date:  2005-04-13       Impact factor: 56.272

6.  Experiences of genetic risk: disclosure and the gendering of responsibility.

Authors:  L d'Agincourt-Canning
Journal:  Bioethics       Date:  2001-06       Impact factor: 1.898

7.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Authors:  Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

8.  Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women.

Authors:  Sarah Charles; Lisa Kessler; Jill E Stopfer; Susan Domchek; Chanita Hughes Halbert
Journal:  Patient Educ Couns       Date:  2006-03-14

9.  Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk.

Authors:  Katrina Armstrong; Barbara Weber; Jill Stopfer; Kathleen Calzone; Mary Putt; James Coyne; J Sanford Schwartz
Journal:  Am J Med Genet A       Date:  2003-03-01       Impact factor: 2.802

10.  Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Authors:  Timothy R Rebbeck; Tara Friebel; Henry T Lynch; Susan L Neuhausen; Laura van 't Veer; Judy E Garber; Gareth R Evans; Steven A Narod; Claudine Isaacs; Ellen Matloff; Mary B Daly; Olufunmilayo I Olopade; Barbara L Weber
Journal:  J Clin Oncol       Date:  2004-02-23       Impact factor: 44.544

View more
  6 in total

1.  Advancing health equity in cancer care: The lived experiences of poverty and access to lung cancer screening.

Authors:  Ambreen Sayani; Mandana Vahabi; Mary Ann O'Brien; Geoffrey Liu; Stephen Hwang; Peter Selby; Erika Nicholson; Meredith Giuliani; Lawson Eng; Aisha Lofters
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

2.  Predictors of genetic beliefs toward cancer risk perceptions among adults in the United States: Implications for prevention or early detection.

Authors:  Lawrence P McKinney; Gemechu B Gerbi; Lee S Caplan; Mechelle D Claridy; Brian M Rivers
Journal:  J Genet Couns       Date:  2020-02-27       Impact factor: 2.717

3.  Genetic Testing Consumers in Italy: A Preliminary Investigation of the Socio-Demographic Profile, Health-Related Habits, and Decision Purposes.

Authors:  Serena Oliveri; Giulia Marton; Laura Vergani; Ilaria Cutica; Alessandra Gorini; Francesca Spinella; Gabriella Pravettoni
Journal:  Front Public Health       Date:  2020-10-08

Review 4.  The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case.

Authors:  Hannah Wand; Joshua W Knowles; Shoa L Clarke
Journal:  Curr Opin Lipidol       Date:  2021-04-01       Impact factor: 4.616

5.  Regarding the Yin and Yang of Precision Cancer- Screening and Treatment: Are We Creating a Neglected Majority?

Authors:  Colleen M McBride; Yue Guan; Jennifer L Hay
Journal:  Int J Environ Res Public Health       Date:  2019-10-29       Impact factor: 3.390

6.  Health Equity in National Cancer Control Plans: An Analysis of the Ontario Cancer Plan.

Authors:  Ambreen Sayani
Journal:  Int J Health Policy Manag       Date:  2019-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.